Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial (Müller) cells

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Japanese Journal of Ophthalmology

• Publication date

  2018-09-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10384-018-0622-5PMID 30250985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells

  2018cited by this paper
• Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy

  2017cited by this paper
• A circadian clock gene, PER2, activates HIF‐1 as an effector molecule for recruitment of HIF‐1α to promoter regions of its downstream genes

  2017cited by this paper
• Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia

  2016cited by this paper
• Different roles played by periostin splice variants in retinal neovascularization.

  2016cited by this paper
• DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor Progression

  2016cited by this paper
• Mitomycin C modulates the circadian oscillation of clock gene period 2 expression through attenuating the glucocorticoid signaling in mouse fibroblasts.

  2015cited by this paper
• The role of clock genes and circadian rhythm in the development of cardiovascular diseases

  2015cited by this paper
• Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1β and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis

  2015cited by this paper
• DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas

  2015cited by this paper
• Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2.

  2015cited by this paper
• MDM2 Regulates Hypoxic Hypoxia-inducible Factor 1α Stability in an E3 Ligase, Proteasome, and PTEN-Phosphatidylinositol 3-Kinase-AKT-dependent Manner*

  2014cited by this paper
• Changes in the Daily Rhythm of Lipid Metabolism in the Diabetic Retina

  2014cited by this paper
• A positive role for PERIOD in mammalian circadian gene expression.

  2014cited by this paper
• Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina.

  2014cited by this paper
• A review of anti-VEGF agents for proliferative diabetic retinopathy

  2014cited by this paper
• Inflammation and Pharmacological Treatment in Diabetic Retinopathy

  2013cited by this paper
• Recent Advances in the Management of Neovascular Glaucoma

  2013cited by this paper
• Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T cells.

  2012cited by this paper
• Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch critical for myocardial adaptation to ischemia

  2012cited by this paper
• SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors

  2012cited by this paper
• Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability

  2011cited by this paper
• Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia-Inducible Factors

  2010cited by this paper
• Shift Work, Jet Lag, and Female Reproduction

  2010cited by this paper
• The mouse retina as an angiogenesis model.

  2010cited by this paper
• The Transcriptional Repressor DEC2 Regulates Sleep Length in Mammals

  2009cited by this paper
• The genetics of mammalian circadian order and disorder: implications for physiology and disease

  2008cited by this paper
• Transcriptional Activation of HIF-1 by RORα and its Role in Hypoxia Signaling

  2008cited by this paper
• Basic‐helix‐loop‐helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression

  2008cited by this paper
• Mimicking Hypoxia by the Chemical Stabilization of Hif-1a in the Mouse Retina

  2007cited by this paper
• Chronopharmacology focused on biological clock.

  2007cited by this paper
• Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.

  2006cited by this paper
• Biological Clocks and Shift Work: Circadian Dysregulation and Potential Long-term Effects

  2006cited by this paper
• Genetics of the sleep-wake cycle and its disorders.

  2006cited by this paper
• Emerging evidence for the interrelationship of xenobiotic exposure and circadian rhythms: a review

  2006cited by this paper
• Retinal angiogenesis in development and disease

  2005cited by this paper
• System-level identification of transcriptional circuits underlying mammalian circadian clocks

  2005cited by this paper
• Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

  2004cited by this paper
• A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells.

  2003cited by this paper
• A clockwork web: circadian timing in brain and periphery, in health and disease

  2003cited by this paper
• Molecular machinery of the circadian clock in mammals

  2002cited by this paper
• Dec1 and Dec2 are regulators of the mammalian molecular clock

  2002cited by this paper
• An hPer2 Phosphorylation Site Mutation in Familial Advanced Sleep Phase Syndrome

  2001cited by this paper
• Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease

  2001cited by this paper
• Three transmembrane conformations and sequence-dependent displacement of the S4 domain in shaker K+ channel gating.

  1998cited by this paper
• Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions.

  1995cited by this paper

• Ferroptosis in diabetic retinopathy: from pathogenic mechanisms to translational prospects.

  2026cites this paper
• Ferroptosis in Müller cells under hyperglycemia: mechanisms and therapeutic implications for diabetic retinopathy-associated optic neuroinflammation

  2025cites this paper
• New Gene Targets for Diagnosis and Therapy of Diabetic Retinopathy

  2025cites this paper
• High expression of DEC2 distinguishes chondroblastic osteosarcoma and promotes tumour growth by activating the VEGFC/VEGFR2 signalling pathway

  2024cites this paper
• Periostin in Angiogenesis and Inflammation in CRC—A Preliminary Observational Study

  2022cites this paper
• Ocular Complications of Obstructive Sleep Apnea

  2021cites this paper
• The Role of HIF1α-PFKFB3 Pathway in Diabetic Retinopathy

  2021cites this paper
• Association of Retinal Vascular Manifestation and Obstructive Sleep Apnea (OSA): A Narrative Review

  2021influential citation
• Retinal vascular manifestations of obstructive sleep apnea.

  2020cites this paper
• Retinal vascular manifestations of obstructive sleep apnea.

  2020cites this paper
• MicroRNA-301a inhibits the progression of osteosarcoma by regulating DEC2.

  2020cites this paper
• Bradykinin alleviates DR retinal endothelial injury by regulating HMGB-1/NF-κB pathway.

  2019cites this paper
• Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells

  2018cites this paper